Preethi Sundaram, PhD

Biography

Preethi joined Catalyst in 2021 as Chief Product Development Officer and was named Chief Strategy Officer in 2022. Preethi joined Catalyst at a pivotal time to advance our rare-disease therapeutic efforts and support patients and families worldwide. She used her extensive experience in corporate strategy, drug development, execution, and partnership-driven portfolio expansion to help grow Catalyst’s pipeline and deliver much-needed new treatment options for rare-disease patients.

“My catalyst is the belief that every patient deserves care grounded in evidence and guided by smart strategy–and the resolve to help make that possible.”

Other Notable Roles:
Global Head, Medical Operations, General Medicines Business Unit, Sanofi
Global Head, Medical Operations, Primary Care Business Unit, Sanofi
Global Project Head, Multiple Therapeutic Area Programs, Sanofi
Global Clinical Research Director, International Development, Sanofi
Project Lead, Immunoscience Development Center, Abbott Laboratories
Project Lead, Covance
Clinical Director, Neurovision
Graduate Teaching Assistant and Clinical Supervisor, West Norwich Hospital, Cambridge, UK
Clinical Faculty, Sankara Nethralaya Eye Hospital, Chennai, India

Board Participation:
Board of Directors, Clicare

Degrees:
Bachelor of Science, Optometry from the Elite School of Optometry & BITS (India)
Bachelor of Arts, Psychology, University of Madras (India)
Doctor of Philosophy in Optometry from Anglia Ruskin University (United Kingdom)
Executive MBA, The London Business School